Warp: I think discussing the difference between a

Warp: I think discussing the difference between a LymPro JV partnership with up front money versus a Master Service Agreement with ICON is a topic worth discussing on an AMBS message board. I don't know why you would want to belittle that discussion?

I brought up the Eltoprazine Trial and the Geneva office and the additional people Gerald has brought on to make a point that our costs have increased significantly in the last several months. And yet, we have not brought in a single grant!! Gerald hired a guy a year ago for the express purpose of securing grants. I am not award of any yet.

Also, by our not getting a JV partnership with up front money that also effects our cash flow and therefore the possible dilution the company may face in the coming 6 to 18 months. Why would this discussion be made fun of? Isn't this the very purpose of a shareholder message board?

If I were a flipper like Solantey, I could understand people questioning my sincerity. But clearly, AMBS is still struggling due to the handling of the LymPro data during the two July Conferences and our stock price at .107 cents today reflects it is no laughing matter!